Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership3,215,415 shares
Latest Disclosed Value $ 211,965,492
Geode Capital Management, Llc reports 5.22% increase in ownership of 1CYTK / Cytokinetics, Incorporated

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 3,215,415 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $173,632,410 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 3,056,017 shares of Cytokinetics, Incorporated. This represents a change in shares of 5.22% during the quarter. The current value of the position is $200,384,663 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 3,215,415 159,398 5.22 211,965 9.14 0.0070
2026-02-09 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 3,056,017 15,815 0.52 194,214 16.22 0.0120
2025-11-12 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 3,040,202 45,757 1.53 167,112 68.89 0.0107
2025-08-08 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 2,994,445 56,961 1.94 98,948 -16.21 0.0069
2025-05-13 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 2,937,484 96,146 3.38 118,084 -11.67 0.0093
2025-02-12 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 2,841,338 -7,246 -0.25 133,686 -11.13 0.0104
2024-11-12 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 2,848,584 109,938 4.01 150,433 1.36 0.0122
2024-08-09 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 2,738,646 491,481 21.87 148,408 -5.82 0.0130
2024-05-13 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 2,247,165 157,040 7.51 157,571 -9.71 0.0146
2024-02-13 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 2,090,125 111,760 5.65 174,525 199.41 0.0183
2023-11-13 2023-09-30 13F CYTOKINETICS COM NEW 23282W605 1,978,365 69,134 3.62 58,290 -6.41 0.0069
2023-08-11 2023-06-30 13F CYTOKINETICS COM NEW 23282W605 1,909,231 174,535 10.06 62,279 2.02 0.0073
2023-05-15 2023-03-31 13F CYTOKINETICS COM NEW 23282W605 1,734,696 76,846 4.64 61,044 81,290.67 0.0079
2023-02-13 2022-12-31 13F CYTOKINETICS COM NEW 23282W605 1,657,850 66,392 4.17 76 -99.90 0.0107
2022-11-14 2022-09-30 13F CYTOKINETICS COM NEW 23282W605 1,591,458 107,936 7.28 77,106 32.29 0.0117
2022-08-12 2022-06-30 13F CYTOKINETICS COM NEW 23282W605 1,483,522 11,611 0.79 58,287 7.58 0.0085
2022-05-13 2022-03-31 13F CYTOKINETICS COM NEW 23282W605 1,471,911 43,289 3.03 54,181 -16.79 0.0068
2022-02-11 2021-12-31 13F CYTOKINETICS COM NEW 23282W605 1,428,622 30,574 2.19 65,116 30.32 0.0078
2021-11-12 2021-09-30 13F CYTOKINETICS COM NEW 23282W605 1,398,048 187,626 15.50 49,966 108.59 0.0067
2021-08-13 2021-06-30 13F CYTOKINETICS COM NEW 23282W605 1,210,422 52,294 4.52 23,954 -11.08 0.0033
2021-05-12 2021-03-31 13F CYTOKINETICS COM NEW 23282W605 1,158,128 102,567 9.72 26,938 22.81 0.0041
2021-02-12 2020-12-31 13F CYTOKINETICS COM NEW 23282W605 1,055,561 52,615 5.25 21,934 1.02 0.0037
2020-11-13 2020-09-30 13F CYTOKINETICS COM NEW 23282W605 1,002,946 131,880 15.14 21,713 5.76 0.0043
2020-08-13 2020-06-30 13F CYTOKINETICS COM NEW 23282W605 871,066 13,310 1.55 20,531 103.04 0.0044
2020-05-14 2020-03-31 13F CYTOKINETICS COM NEW 23282W605 857,756 57,784 7.22 10,112 19.15 0.0026
2020-02-20 2019-12-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 799,972 8,303 1.05 8,487 -5.78 0.0018
2020-02-13 2019-12-31 13F CYTOKINETICS COM NEW 23282W605 799,972 8,303 8,487 1,081.5937
2019-11-12 2019-09-30 13F CYTOKINETICS COM NEW 23282W605 791,669 37,536 4.98 9,008 6.19 0.0021
2019-08-14 2019-06-30 13F CYTOKINETICS COM NEW 23282W605 754,133 82,998 12.37 8,483 56.25 0.0021
2019-05-14 2019-03-31 13F CYTOKINETICS COM NEW 23282W605 671,135 85,592 14.62 5,429 46.73 0.0014
2019-03-06 2018-12-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 585,543 70,954 13.79 3,700 -26.99 0.0011
2019-02-13 2018-12-31 13F CYTOKINETICS COM NEW 23282W605 585,543 70,954 3,700
2018-11-13 2018-09-30 13F CYTOKINETICS COM NEW 23282W605 514,589 18,139 3.65 5,068 23.01 0.0014
2018-08-14 2018-06-30 13F CYTOKINETICS COM NEW 23282W605 496,450 62,330 14.36 4,120 31.84 0.0013
2018-05-15 2018-03-31 13F CYTOKINETICS COM NEW 23282W605 434,120 5,572 1.30 3,125 -10.51 0.0010
2018-02-13 2017-12-31 13F CYTOKINETICS COM NEW 23282W605 428,548 6,813 1.62 3,492 -42.89 0.0012
2017-11-14 2017-09-30 13F CYTOKINETICS COM NEW 23282W605 421,735 -26,541 -5.92 6,115 12.74 0.0023
2017-08-14 2017-06-30 13F CYTOKINETICS COM NEW 23282W605 448,276 151,593 51.10 5,424 42.29 0.0021
2017-06-21 2017-03-31 13F/A-1 CYTOKINETICS INC COM COM NEW 23282W605 296,683 11,747 4.12 3,812 10.14 0.0016
2017-05-12 2017-03-31 13F CYTOKINETICS INC COM COM NEW 23282W605 296,683 3,812
2017-02-14 2016-12-31 13F CYTOKINETICS INC COM COM NEW 23282W605 284,936 11,268 4.12 3,461 37.78 0.0016
2016-11-10 2016-09-30 13F CYTOKINETICS INC COM COM NEW 23282W605 273,668 1,817 0.67 2,512 -2.60 0.0013
2016-08-12 2016-06-30 13F CYTOKINETICS INC COM COM NEW 23282W605 271,851 -6,979 -2.50 2,579 31.25 0.0014
2016-05-13 2016-03-31 13F CYTOKINETICS INC COM COM NEW 23282W605 278,830 -47,250 -14.49 1,965 -42.36 0.0010
2016-02-12 2015-12-31 13F CYTOKINETICS INC COM COM NEW 23282W605 326,080 41,767 14.69 3,409 79.23 0.0019
2015-11-13 2015-09-30 13F CYTOKINETICS INC COM COM NEW 23282W605 284,313 87,835 44.70 1,902 44.09 0.0012
2015-08-14 2015-06-30 13F CYTOKINETICS INC COM COM NEW 23282W605 196,478 1,402 0.72 1,320 -0.15 0.0008
2015-05-14 2015-03-31 13F CYTOKINETICS INC COM COM NEW 23282W605 195,076 33,434 20.68 1,322 2.16 0.0008
2015-02-12 2014-12-31 13F CYTOKINETICS INC COM COM NEW 23282W605 161,642 231 0.14 1,294 127.82 0.0008
2014-11-14 2014-09-30 13F CYTOKINETICS INC COM COM NEW 23282W605 161,411 3,088 1.95 568 -24.87 0.0004
2014-08-13 2014-06-30 13F CYTOKINETICS INC COM COM NEW 23282W605 158,323 2,776 1.78 756 -48.82 0.0005
2014-05-14 2014-03-31 13F CYTOKINETICS INC COM COM NEW 23282W605 155,547 32,582 26.50 1,477 84.86 0.0010
2014-02-14 2013-12-31 13F CYTOKINETICS INC COM COM NEW 23282W605 122,965 1,833 1.51 799 -13.06 0.0006
2013-11-14 2013-09-30 13F CYTOKINETICS INC COM COM NEW 23282W605 121,132 29,644 32.40 919 -13.14 0.0007
2013-08-14 2013-06-30 13F CYTOKINETICS INC COM COM 23282W605 91,488 91,488 1,058 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.